Literature DB >> 31983026

Is the anatomical distribution of low-grade gliomas linked to regions of gliogenesis?

Anne Jarstein Skjulsvik1,2, Hans Kristian Bø3,4, Asgeir Store Jakola5,6,7, Erik Magnus Berntsen4,8, Lars Eirik Bø9, Ingerid Reinertsen9, Kristin Smistad Myrmel10, Kristin Sjåvik11, Kristin Åberg10, Thomas Berg10, Hong Yan Dai12, Roar Kloster11, Sverre Helge Torp12,13, Ole Solheim14,7.   

Abstract

INTRODUCTION: According to the stem cell theory, two neurogenic niches in the adult human brain may harbor cells that initiate the formation of gliomas: The larger subventricular zone (SVZ) and the subgranular zone (SGZ) in the hippocampus. We wanted to explore whether defining molecular markers in low-grade gliomas (LGG; WHO grade II) are related to distance to the neurogenic niches.
METHODS: Patients treated at two Norwegian university hospitals with population-based referral were included. Eligible patients had histopathological verified supratentorial low-grade glioma. IDH mutational status and 1p19q co-deletion status was retrospectively assessed. 159 patients were included, and semi-automatic tumor segmentation was done from pre-treatment T2-weighted (T2W) or Fluid-Attenuated Inversion Recovery (FLAIR) images. 3D maps showing the anatomical distribution of the tumors were then created for each of the three molecular subtypes (IDH mutated/1p19q co-deleted, IDH mutated and IDH wild-type). Both distance from tumor center and tumor border to the neurogenic niches were recorded.
RESULTS: In this population-based cohort of previously untreated low-grade gliomas, we found that low-grade gliomas are more often found closer to the SVZ than the SGZ, but IDH wild-type tumors are more often found near SGZ.
CONCLUSION: Our study suggests that the stem cell origin of IDH wild-type and IDH mutated low-grade gliomas may be different.

Entities:  

Keywords:  1p19q co-deletion; 3D brain map; IDH mutation; Low-grade glioma; Subgranular zone; Subventricular zone

Year:  2020        PMID: 31983026     DOI: 10.1007/s11060-020-03409-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  6 in total

1.  Stemness and clinical features in relation to the subventricular zone in diffuse lower-grade glioma: an exploratory study.

Authors:  Alba Corell; Tomás Gómez Vecchio; Sandra Ferreyra Vega; Anna Dénes; Alice Neimantaite; Alexander Hagerius; Hanna Barchéus; Ole Solheim; Cecilia Lindskog; Thomas Olsson Bontell; Helena Carén; Asgeir S Jakola; Anja Smits
Journal:  Neurooncol Adv       Date:  2022-06-04

2.  Preoperative Patient-Reported Outcomes in Suspected Low-Grade Glioma: Markers of Disease Severity and Correlations with Molecular Subtypes.

Authors:  Dongni Buvarp; Isabelle Rydén; Katharina S Sunnerhagen; Thomas Olsson Bontell; Tomás Gómez Vecchio; Anja Smits; Asgeir Store Jakola
Journal:  J Clin Med       Date:  2021-02-08       Impact factor: 4.241

3.  Lower-Grade Gliomas: An Epidemiological Voxel-Based Analysis of Location and Proximity to Eloquent Regions.

Authors:  Tomás Gómez Vecchio; Alice Neimantaite; Alba Corell; Jiri Bartek; Margret Jensdottir; Ingerid Reinertsen; Ole Solheim; Asgeir S Jakola
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

Review 4.  Regional Development of Glioblastoma: The Anatomical Conundrum of Cancer Biology and Its Surgical Implication.

Authors:  Ciro De Luca; Assunta Virtuoso; Michele Papa; Francesco Certo; Giuseppe Maria Vincenzo Barbagallo; Roberto Altieri
Journal:  Cells       Date:  2022-04-15       Impact factor: 7.666

5.  Adult isocitrate dehydrogenase-mutant brainstem glioma: illustrative case.

Authors:  Vincent C Ye; Alexander P Landry; Teresa Purzner; Aristotelis Kalyvas; Nilesh Mohan; Philip J O'Halloran; Andrew Gao; Gelareh Zadeh
Journal:  J Neurosurg Case Lessons       Date:  2021-03-22

6.  Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET.

Authors:  Hiroyuki Tatekawa; Akifumi Hagiwara; Hiroyuki Uetani; Shadfar Bahri; Catalina Raymond; Albert Lai; Timothy F Cloughesy; Phioanh L Nghiemphu; Linda M Liau; Whitney B Pope; Noriko Salamon; Benjamin M Ellingson
Journal:  Cancer Imaging       Date:  2021-03-10       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.